申请人:ARRAY BIOPHARMA INC.
公开号:US20170362240A1
公开(公告)日:2017-12-21
Compounds of Formula I: and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R
1
, R
2
, R
3
and R
4
have the meanings given in the specification, are inhibitors of one or more JAK kinases and are useful in the treatment of JAK kinase-associated diseases and disorders, such as autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their co-morbidities.